(TH9507) is a synthetic growth hormone–releasing hormone (GHRH) analogue that selectively stimulates the pituitary to secrete growth hormone (GH). It is widely studied for its effects on IGF-1 elevation, visceral fat reduction, and metabolic profile improvement in preclinical and in vitro research models. Researchers utilize (TH9507) to explore GH/IGF-1 axis regulation, fat redistribution, body composition, and metabolic syndrome mechanisms. Its high specificity for GHRH receptors and well-characterized pharmacokinetics make it a reliable tool for endocrine and metabolic studies. For Laboratory and Scientific Research Use Only. Not for Human Consumption. Why Researchers Choose (TH9507) Highly Specific GHRH Analogue: Stimulates physiologic GH release without desensitizing pituitary receptors. Metabolic Relevance: Demonstrated ability to reduce visceral adiposity and improve lipid profiles in research models. Extended Half-Life: Engineered to resist DPP-IV degradation, supporting once-daily dosing studies. Purity & Reliability: ≥98% peptide purity ensures reproducible experimental results. Batch Verified: Identity and potency confirmed for every lot. Important Note For laboratory and scientific research only. Not for human consumption, veterinary use, or diagnostic purposes.